Quinten Health ’s Post

May is #VisionHealthMonth. Hear from our trainees on their research on vision-related diseases. Victor Pham Truong is an MSc student in Dr. Valerie Wallace's lab at the Donald K. Johnson Eye Institute, University Health Network. His research focuses on studying #photoreceptor transplantation, by connecting #neurons and growing #axons to treat #vision illnesses and #blindness. #TraineeTuesday #KrembilResearchDay

In her piece for Genetic Alliance UK, Rebecca Starkie, Sr. Director of Patient Engagement, discusses how clinical research studies are paving the way for hope and breakthroughs for rare disease patients worldwide. Read the blog: https://hubs.la/Q02CxW6K0 #ClinicalResearch #RareDisease

Knowing that cancer runs in your family is scary. It can feel like your future has already been decided but Your genetics could be your best ally to potentially mitigating your cancer risk. Genetic testing revolutionizes the fight against cancer, offering early detection and personalized strategies to reduce your risk. Breakthroughs in genetic testing, such as identifying BRCA1 and BRCA2 mutations (breast cancer) and Lynch syndrome (colorectal cancer), are empowering individuals with knowledge and actionable strategies to mitigate their cancer risks. With advancements like polygenic risk scores and multi-cancer early detection tests, we're not just fighting cancer on a personal level; we're shifting towards a culture of preventive healthcare. Check out this blog post by my colleague and co-founder, William Stanford MD, PhD that dives into more detail on how cancer risk awareness coupled with action is an important component in the fight against cancer. https://lnkd.in/ggV8yQGW #CancerPrevention #GeneticTesting #PrecisionMedicine #ProactiveHealthcare #EarlyDetection #PersonalizedMedicine

🚨🔬The latest publication from the NECESSITY consortium sheds light on Sjögren’s disease, a condition known for its heterogeneity and lack of clear classification for the variety of symptoms observed in Sjögren’s patients. Using cluster analysis based on subjective symptoms, clinical, and biological manifestations, the study identified 3 distinct subgroups. In total 26 variables were used to cluster the population into these subgroups, to also allow for a comparative analysis of the prognosis between the three. The #findings suggest that the three subgroups represent different heterogeneous #pathophysiological disease mechanisms, stages of disease, or both. These #subgroups can be used further for the #stratification of patients in future #therapeutic trials! Read more about this groundbreaking research in our latest publication, with special thanks to Yann Nguyen, Pr Raphaèle Seror (MD, PhD), Gaetane Nocturne, PhD, Fai Ng for their efforts on this study! Our article link: https://lnkd.in/edmEgcrv #SjögrensDisease #NECESSITYConsortium #ResearchPublication #MedicalScience

An extensive review (https://bit.ly/4bro1rp) on ME/CFS from a multidisciplinary team, including researchers and clinicians, has recently been published. The paper focuses on “describing ME/CFS in terms of symptoms, severity and burden, diagnostic criteria, causes and triggers; followed by an overview of the complex pathophysiology and management of the condition.” Whilst not necessarily providing new information about ME/CFS, this review pools together information from multiple sources to provide a helpful overview of this complex disease. Read more: https://lnkd.in/d2g_uN-q #MyalgicEncephalomyelitis #MECFS #pwME #myalgicE

We're proud to offer HealthFLD, Nanox AI's FDA cleared fully automated AI software for liver attenuation analysis from CT scans for non-invasive assessment. Early detection can save lives! Learn more: https://brnw.ch/21wKzrs On #InternationalNASHDay, we raise awareness about the global public health crisis of fatty liver disease, affecting over 115 million people worldwide. NASH is nonalcoholic steatohepatitis, the most severe form of nonalcoholic fatty liver disease (NAFLD), a condition in which the liver builds up excessive fat deposits, often causing cirrhosis that might lead to liver failure. #FattyLiverDisease #NASHDay #NASH #Innovation

Bridging Medicine and Technology for Neurodegenerative Research In our upcoming webinar, we'll explore the intersection of medical expertise and technological innovation, particularly how our patented platform is transforming the fight against neurodegenerative diseases. This is an opportunity to see the future of #clinicaltrials 📅 Mar 7, 9 AM MST 🔗 https://lnkd.in/gFWGyGCn #clinicaltrialsinnovation #medicalwebinar #webinar #asgct24 #clinicalresearch

Life science innovations have offered new hope in the last decade or two for people with neurodegenerative diseases. Novel approaches today may improve outcomes tomorrow, industry leaders such as Katrine Bosley of DaCapo Brainscience told Orrick’s Thora Johnson and Neel Lilani in our recent report with PitchBook on life science financing. Join the conversation.   https://lnkd.in/ex7ud-rG #NeurodegenerativeDisease #Neurodegenerative #LifeScienceFinancing #HealthTech #LifeSciences

Have you ever suffered from itchy skin in your daily life? Recently, a groundbreaking #PKUResearch reveals the molecular mystery of cholestatic itch, revolutionizing liver disease treatments! 🔬✨ Tackling the issue of cholestatic itch, scientists have been exploring novel solutions. Recently, #PKU researchers led by Prof. Lei Xiaoguang, in collaboration with PKU Prof. Li Yulong and Prof. Chen Yu from Beijing You'an Hospital, uncovered how bile acids activate hX4 to induce cholestatic itch. This work promotes a new treatment strategy for liver disease that avoids itch side effects! The findings were published in Cell. 🔍: https://lnkd.in/gYk7exm8 📄: https://lnkd.in/gF9V6z6f

NEW: This module discusses the pathophysiology that leads to the clinical manifestations of Sickle Cell disease and outline the assessment and management of the patients. Published by our Author Prize Winner, you can find the #LearningSession here: https://lnkd.in/emapxJN7